Literature DB >> 16429107

Potassium handling in health and disease: lessons from inherited tubulopathies.

Daniel Landau1.   

Abstract

UNLABELLED: The tight regulation of plasma potassium levels, a mostly intracellular cation, is essential given the severe consequences of hyper- and hypokalemia. Basic renal physiology studies in the past have identified the complex pathway of potassium reabsorption in the proximal tubule followed by the fine-tuning of its secretion or reabsorption at the distal tubule, including the thick ascending limb of Henle's loop, the distal convoluted tubule and the cortical collecting duct. Genetic studies in recent years have clarified the role of specific tubular channels and transporters in the pathogenesis of unique hyperand hypokalemic tubulopathies, some of them non-hypertensive (pseudohypoaldosteronism, Bartter and Gitelman syndromes) and others hypertensive by definition (including Liddle and Gordon syndromes). This article reviews the genetic and clinical spectrum of hypokalemic and hyperkalemic tubulopathies. ABBREVIATIONS: K: potassium, Na: sodium; Cl: chloride; BS: Bartter syndrome; PHA: pseudohypoaldosteronism; NKCC2: bumetanide-sensitive Na-K-2Cl- co-transporter; ROMK: inwardly rectifying K channel; ClC-Kb: basolateral Cl channel; TAL: thick ascending limb of Henle's loop; TSC: thiazide-sensitive NaCl co-transporter; CCD: cortical collecting duct; ENaC: epithelial Na channel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16429107

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  2 in total

1.  A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism.

Authors:  Kandai Nozu; Xue Jun Fu; Hiroshi Kaito; Kyoko Kanda; Naoki Yokoyama; Rafal Przybyslaw Krol; Toshihiro Nakajima; Mizutaka Kajiyama; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2007-03-31       Impact factor: 3.714

2.  Association of Mutations in SLC12A1 Encoding the NKCC2 Cotransporter With Neonatal Primary Hyperparathyroidism.

Authors:  Dong Li; Lifeng Tian; Cuiping Hou; Cecilia E Kim; Hakon Hakonarson; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2016-03-10       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.